Department of Microbiology and Immunology
Lorena E. Brown has not added Biography.
If you are Lorena E. Brown and would like to personalize this page please email our Author Liaison for assistance.
Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus.
Journal of virology May, 2002 | Pubmed ID: 11932386
Identification of antigenically active tryptic fragments of apical membrane antigen-1 (AMA1) of Plasmodium chabaudi malaria: strategies for assembly of immunologically active peptides.
Vaccine Oct, 2002 | Pubmed ID: 12297393
Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.
Journal of immunology (Baltimore, Md. : 1950) Nov, 2002 | Pubmed ID: 12391202
Immune responses in hepatitis C virus infection: the role of dendritic cells.
Immunology and cell biology Feb, 2003 | Pubmed ID: 12534948
Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus.
Immunology and cell biology Feb, 2003 | Pubmed ID: 12534949
Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.
Proceedings of the National Academy of Sciences of the United States of America Mar, 2003 | Pubmed ID: 12601154
Responses against complex antigens in various models of CD4 T-cell deficiency: surprises from an anti-CD4 antibody transgenic mouse.
Immunologic research , 2004 | Pubmed ID: 15258307
A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses.
Proceedings of the National Academy of Sciences of the United States of America Oct, 2004 | Pubmed ID: 15489266
ISCOM-based vaccines: the second decade.
Immunology and cell biology Apr, 2005 | Pubmed ID: 15748208
Lipid-based self-adjuvanting vaccines.
Current drug delivery Oct, 2005 | Pubmed ID: 16305441
Targeting CD45RB alters T cell migration and delays viral clearance.
International immunology Feb, 2006 | Pubmed ID: 16361310
Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.
European journal of immunology Mar, 2006 | Pubmed ID: 16435281
Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines.
International immunology Dec, 2006 | Pubmed ID: 17077175
Pandemic vaccines: promises and pitfalls.
The Medical journal of Australia Nov, 2006 | Pubmed ID: 17115955
Antiviral activity of the long chain pentraxin PTX3 against influenza viruses.
Journal of immunology (Baltimore, Md. : 1950) Mar, 2008 | Pubmed ID: 18292565
A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection.
Vaccine Sep, 2008 | Pubmed ID: 18455278
Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.
Vaccine Oct, 2008 | Pubmed ID: 18725260
Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells.
Immunity Feb, 2009 | Pubmed ID: 19200758
Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.
Immunology and cell biology May-Jun, 2009 | Pubmed ID: 19308073
Single dose intranasal immunization with ISCOMATRIX vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tract.
Vaccine Apr, 2009 | Pubmed ID: 19368789
Lipopeptide vaccines illustrate the potential role of subtype-crossreactive T cells in the control of highly virulent influenza.
Influenza and other respiratory viruses Jul, 2009 | Pubmed ID: 19627375
Q&A: What have we found out about the influenza A (H1N1) 2009 pandemic virus?
Journal of biology , 2009 | Pubmed ID: 19769786
Influenza A virus facilitates Streptococcus pneumoniae transmission and disease.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Jun, 2010 | Pubmed ID: 20097876
A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody.
Immunology and cell biology Jul, 2010 | Pubmed ID: 20177411
Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model.
PloS one , 2010 | Pubmed ID: 20422002
Role of CD8(+) T-cell immunity in influenza infection: potential use in future vaccine development.
Expert review of respiratory medicine Oct, 2009 | Pubmed ID: 20477341
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals.
Journal of hepatology Oct, 2010 | Pubmed ID: 20667615
The role of adjuvants in vaccines for seasonal and pandemic influenza.
Vaccine Nov, 2010 | Pubmed ID: 20849874
Prevention and treatment of influenza with hyperimmune bovine colostrum antibody.
PloS one , 2010 | Pubmed ID: 21049034
Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization.
Journal of controlled release : official journal of the Controlled Release Society Jun, 2011 | Pubmed ID: 21371510
The role of neutrophils during mild and severe influenza virus infections of mice.
PloS one , 2011 | Pubmed ID: 21423798
The linear range for accurately quantifying antigen-specific T-cell frequencies by tetramer staining during natural immune responses.
European journal of immunology May, 2011 | Pubmed ID: 21469136
Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin.
Journal of controlled release : official journal of the Controlled Release Society Oct, 2011 | Pubmed ID: 22063004
Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses.
Journal of controlled release : official journal of the Controlled Release Society Jan, 2012 | Pubmed ID: 22306334
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados